Speece Thorson Capital Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Buy
64,431
+12,366
+24% +$3.02M 3.25% 10
2025
Q4
$13.2M Sell
52,065
-2,912
-5% -$731K 2.86% 18
2025
Q3
$13.6M Sell
54,977
-610
-1% -$146K 2.72% 19
2025
Q2
$13.4M Sell
55,587
-10,071
-15% -$2.34M 2.72% 20
2025
Q1
$14.9M Sell
65,658
-1,097
-2% -$241K 3.06% 11
2024
Q4
$13.7M Sell
66,755
-334
-0.5% -$73.3K 2.71% 18
2024
Q3
$16.3M Sell
67,089
-212
-0.3% -$49.6K 3.01% 12
2024
Q2
$14.8M Sell
67,301
-1,208
-2% -$262K 3.02% 9
2024
Q1
$15.4M Sell
68,509
-882
-1% -$199K 2.98% 10
2023
Q4
$15.3M Sell
69,391
-8,914
-11% -$1.89M 3.13% 10
2023
Q3
$17.2M Sell
78,305
-9,814
-11% -$2.22M 3.79% 4
2023
Q2
$19.8M Sell
88,119
-1,027
-1% -$206K 4.06% 3
2023
Q1
$17.1M Buy
89,146
+8,498
+11% +$1.64M 3.59% 6
2022
Q4
$14.9M Buy
80,648
+25,459
+46% +$4.48M 3.2% 8
2022
Q3
$9.18M Buy
55,189
+24,507
+80% +$4.99M 2.09% 28
2022
Q2
$6.33M Buy
30,682
+187
+0.6% +$42.2K 1.49% 34
2022
Q1
$7.37M Sell
30,495
-4,769
-14% -$1.11M 1.58% 34
2021
Q4
$8.58M Buy
35,264
+122
+0.3% +$27.9K 1.64% 28
2021
Q3
$7.18M Sell
35,142
-70
-0.2% -$15K 1.5% 30
2021
Q2
$7.26M Sell
35,212
-169
-0.5% -$34K 1.52% 29
2021
Q1
$6.74M Buy
35,381
+11,582
+49% +$2.15M 1.42% 28
2020
Q4
$4.51M Sell
23,799
-315
-1% -$58.8K 1.07% 35
2020
Q3
$4.25M Buy
24,114
+104
+0.4% +$16.6K 1.13% 34
2020
Q2
$3.68M Sell
24,010
-9,624
-29% -$1.47M 1.06% 34
2020
Q1
$4.71M Sell
33,634
-493
-1% -$73.7K 1.62% 28
2019
Q4
$5.2M Sell
34,127
-12,168
-26% -$1.78M 1.35% 34
2019
Q3
$6.69M Sell
46,295
-28,385
-38% -$4.24M 1.79% 29
2019
Q2
$11.1M Sell
74,680
-13,431
-15% -$1.79M 2.96% 13
2019
Q1
$11.3M Sell
88,111
-3,264
-4% -$384K 3.1% 12
2018
Q4
$9.76M Sell
91,375
-9,711
-10% -$1.08M 2.92% 14
2018
Q3
$11.6M Sell
101,086
-16,633
-14% -$1.88M 2.68% 14
2018
Q2
$12.4M Sell
117,719
-3,277
-3% -$330K 2.61% 17
2018
Q1
$11.3M Sell
120,996
-8,433
-7% -$767K 2.4% 20
2017
Q4
$11.3M Sell
129,429
-921
-0.7% -$82.2K 2.25% 22
2017
Q3
$11.5M Sell
130,350
-26,049
-17% -$2.21M 2.4% 20
2017
Q2
$12.7M Buy
156,399
+755
+0.5% +$57.4K 2.66% 20
2017
Q1
$10.8M Buy
155,644
+4,278
+3% +$296K 2.29% 22
2016
Q4
$10.2M Buy
151,366
+73,670
+95% +$5M 2.28% 24
2016
Q3
$5.68M Buy
77,696
+707
+0.9% +$49.9K 1.22% 38
2016
Q2
$5.29M Buy
76,989
+1,012
+1% +$70.9K 1.15% 40
2016
Q1
$5.4M Buy
75,977
+1,086
+1% +$73.5K 1.21% 38
2015
Q4
$5.64M Sell
74,891
-28,350
-27% -$2.05M 1.37% 35
2015
Q3
$6.71M Sell
103,241
-300
-0.3% -$19.8K 1.67% 32
2015
Q2
$6.67M Sell
103,541
-790
-0.8% -$53.3K 1.6% 30
2015
Q1
$7.33M Buy
104,331
+1,470
+1% +$97K 1.72% 31
2014
Q4
$6.67M Sell
102,861
-73,450
-42% -$4.54M 1.62% 31
2014
Q3
$9.51M Sell
176,311
-14,940
-8% -$812K 2.43% 19
2014
Q2
$10.2M Sell
191,251
-51,249
-21% -$2.64M 2.6% 18
2014
Q1
$11.6M Buy
242,500
+80,400
+50% +$3.77M 3.05% 12
2013
Q4
$7.79M Sell
162,100
-2,310
-1% -$106K 2.07% 27
2013
Q3
$7.06M Buy
164,410
+46,750
+40% +$2.03M 1.95% 28
2013
Q2
$5.04M Buy
+117,660
New +$5.06M 1.47% 35

Other funds holding STE

Speece Thorson Capital Group's STE Position: Q1 2026 in Review

Speece Thorson Capital Group increased its Steris (STE) stake by 24% in Q1 2026, buying an estimated $3.02M and bringing the position to 64,431 shares worth $14.2M. The position accounts for 3.25% of the portfolio, ranked #10.

Speece Thorson Capital Group first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.8M in Q2 2023. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Speece Thorson Capital Group held 64,431 shares of Steris worth $14.2M as of Q1 2026.
  • Speece Thorson Capital Group bought 12,366 Steris shares in Q1 2026, an estimated $3.02M.
  • Steris made up 3.25% of Speece Thorson Capital Group's portfolio in Q1 2026, its #10 holding.
  • Speece Thorson Capital Group first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Speece Thorson Capital Group's Steris position peaked at $19.8M in Q2 2023.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Speece Thorson Capital Group's 13F filing for Q1 2026, filed 29 Apr 2026.